vfend
Generic: voriconazole
Labeler: roerigDrug Facts
Product Profile
Brand Name
vfend
Generic Name
voriconazole
Labeler
roerig
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
voriconazole 50 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0049-3170
Product ID
0049-3170_cf9f1b2e-eeb4-48bb-9f1a-c2b8d94dfbea
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA021266
Marketing Start
2003-03-28
Marketing End
2026-06-30
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
00493170
Hyphenated Format
0049-3170
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
vfend (source: ndc)
Generic Name
voriconazole (source: ndc)
Application Number
NDA021266 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 50 mg/1
Packaging
- 30 TABLET, FILM COATED in 1 BOTTLE (0049-3170-30)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "cf9f1b2e-eeb4-48bb-9f1a-c2b8d94dfbea", "openfda": {"nui": ["N0000175487", "M0002083", "N0000182141", "N0000182140", "N0000185504"], "unii": ["JFU09I87TR"], "rxcui": ["349434", "349435", "351209", "352218", "352219", "352220", "465355", "546624"], "spl_set_id": ["ce3ef5cf-3087-4d92-9d94-9eb8287228db"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "manufacturer_name": ["Roerig"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (0049-3170-30)", "package_ndc": "0049-3170-30", "marketing_end_date": "20260630", "marketing_start_date": "20030328"}], "brand_name": "VFEND", "product_id": "0049-3170_cf9f1b2e-eeb4-48bb-9f1a-c2b8d94dfbea", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Azole Antifungal [EPC]", "Azoles [CS]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]"], "product_ndc": "0049-3170", "generic_name": "voriconazole", "labeler_name": "Roerig", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VFEND", "active_ingredients": [{"name": "VORICONAZOLE", "strength": "50 mg/1"}], "application_number": "NDA021266", "marketing_category": "NDA", "marketing_end_date": "20260630", "marketing_start_date": "20030328"}